National Data Archive
Data Catalog
  • Home
  • Microdata Catalog
  • Citations
  • Login
    Login
    Home / Central Data Catalog / FRESH-83199-EN
central

Impact of Combined Neoadjuvant Chemotherapy on the Complete Pathological Response Rate in Triple-Negative Breast Cancer

France, 2026 - 3000
Reference ID
FReSH-83199-en
Producer(s)
Tohmas;Martin
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Sep 08, 2026
Last modified
Sep 11, 2026
Page views
10
  • Study Description
  • Get Microdata
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts
  • Metadata production
  • Identification

    Survey ID number

    FReSH-83199-en

    Title

    Impact of Combined Neoadjuvant Chemotherapy on the Complete Pathological Response Rate in Triple-Negative Breast Cancer

    Abbreviation or Acronym

    ICNCP

    Country
    Name Country code
    France fr
    Abstract

    This study explores the efficacy of a neoadjuvant chemotherapy regimen in patients with locally advanced triple-negative breast cancer. The primary objective is to determine the rate of pathological complete response after treatment, as well as to evaluate tolerability and associated side effects. Patients are followed for a period of 24 months to also analyze recurrence-free survival and overall survival, with particular attention paid to biomarkers predictive of treatment response.

    Kind of Data

    ['Clinical data','Paraclinical data (non-biological)','Paraclinical data (non-biological) : Anthropometry','Paraclinical data (non-biological) : Function testing','Other']

    Unit of Analysis

    Individus

    Scope

    Topics
    Topic Vocabulary
    Healthcare system determinants health determinant
    Healthcare system determinants: Access to care health determinant
    Healthcare system determinants: Quality of care health determinant
    Behavioral determinants health determinant
    Behavioral determinants: Eating habits health determinant
    Behavioral determinants: Hygiene health determinant
    Other health determinant
    Other factors, details other determinant
    Keywords
    Free keywords

    Coverage

    Geographic Coverage

    ['Ile-de-France','Mayotte','Provence - Alpes - Côte d'Azur']

    Universe

    {
    "level_sex_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D005260"
    },
    "value": "Female"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008297"
    },
    "value": "Male"
    }
    ],
    "level_age_clusion_I": [
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D055815"
    },
    "value": "Young Adult (19 to 24 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000328"
    },
    "value": "Adult (25 to 44 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D008875"
    },
    "value": "Middle Aged (45 to 64 years)"
    },
    {
    "concept": {
    "vocab": "MeSH",
    "vocabURI": "D000368"
    },
    "value": "Aged (65 to 79 years)"
    }
    ],
    "level_type_clusion_I": "General population",
    "level_type_clusion_other": "",
    "clusion_I": "",
    "clusion_E": ""
    }

    Producers and sponsors

    Primary investigators
    Name
    Tohmas;Martin
    Producers
    Name Role
    AGENCE DE L ENVIRONNEMENT ET DE LA MAITRISE DE L ENERGIE (ADEME) sponsor
    Funding Agency/Sponsor
    Name
    AEPEI (ASSOCIATION POUR L'ETUDE ET LA PREVENTION DES L'ENDOCARDITE INFECTIEUSE)
    Other Identifications/Acknowledgments
    Name
    Pharm ;10
    ABBVIE

    Study authorization

    Agency
    Agency name
    ANSM
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Administrative database (employees, pupils, students, etc.)','Disease and death registry','Other']

    Sampling Procedure

    ['{"concept":{"vocab":"CESSDA","vocabURI":"Probability"},"value":"Probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Nonprobability"},"value":"Non-probability"}','{"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}']

    Survey instrument

    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    2026-09-08 3000-01-01
    Frequency of Data Collection

    Collection Frequency *

    Mode of data collection
    • {"concept":{"vocab":"CESSDA","vocabURI":"Transcription"},"value":"Converting or copying information into a structured record"}
    • {"concept":{"vocab":"CESSDA","vocabURI":"SelfAdministeredQuestionnaire"},"value":"Self-administered questionnaire"}
    • {"concept":{"vocab":"CESSDA","vocabURI":"Other"},"value":"Other"}

    Study activities

    Study activities
    Study activities
    Type
    primary evaluation
    Description
    Primary evaluation (assessment) criterion *
    Study activities
    Type
    secondary evaluation

    Data Access

    Access authority
    Name Email
    Thomas;MARTIN med8@impact-dev.tn
    Availability Status

    {"extLink":{"title":"COAR","uri":"http://purl.org/coar/access_right/c_abf2"},"value":"Open access"}

    Contacts

    Contacts
    Name Email
    Thomas;MARTIN med8@impact-dev.tn
    Pharm ;10 pharm10@impact-dev.tn

    Metadata production

    DDI Document ID

    FReSH-83199-en

    Producers
    Name
    Tohmas Martin
    Back to Catalog
    National Data Archive

    © National Data Archive, All Rights Reserved.